Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Gut Microbiota and Metabolites for Very Preterm Infants Through Oropharyngeal Administration of Colostrum: Protocol for a Multicenter Randomized Controlled Trial

NCT05481866 is registered in ClinicalTrials.gov with Shenzhen People's Hospital as lead sponsor.

NCT NCT05481866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05481866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Gut Microbiota and Metabolites for Very Preterm Infants Through Oropharyngeal Administration of Colostrum: Protocol for a Multicenter Randomized Controlled Trial
Lead sponsor
Shenzhen People's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2022
Completion date
October 31, 2023
Enrollment
320 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gut microbiota, metabolites